243 related articles for article (PubMed ID: 25313369)
1. Exploring the role of metformin in anticancer treatments: a systematic review.
Miranda VC; Barroso-Sousa R; Glasberg J; Riechelmann RP
Drugs Today (Barc); 2014 Sep; 50(9):623-40. PubMed ID: 25313369
[TBL] [Abstract][Full Text] [Related]
2. Metformin: a new option in cancer treatment.
Belda-Iniesta C; Pernía O; Simó R
Clin Transl Oncol; 2011 Jun; 13(6):363-7. PubMed ID: 21680296
[TBL] [Abstract][Full Text] [Related]
3. The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.
Gong J; Kelekar G; Shen J; Shen J; Kaur S; Mita M
Target Oncol; 2016 Aug; 11(4):447-67. PubMed ID: 26864078
[TBL] [Abstract][Full Text] [Related]
4. Metformin: A Novel but Controversial Drug in Cancer Prevention and Treatment.
Sui X; Xu Y; Wang X; Han W; Pan H; Xiao M
Mol Pharm; 2015 Nov; 12(11):3783-91. PubMed ID: 26430787
[TBL] [Abstract][Full Text] [Related]
5. Metformin in cancer.
Mallik R; Chowdhury TA
Diabetes Res Clin Pract; 2018 Sep; 143():409-419. PubMed ID: 29807101
[TBL] [Abstract][Full Text] [Related]
6. New perspective for an old antidiabetic drug: metformin as anticancer agent.
Leone A; Di Gennaro E; Bruzzese F; Avallone A; Budillon A
Cancer Treat Res; 2014; 159():355-76. PubMed ID: 24114491
[TBL] [Abstract][Full Text] [Related]
7. Molecular targets of metformin antitumor action.
Sośnicki S; Kapral M; Węglarz L
Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
[TBL] [Abstract][Full Text] [Related]
8. Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin.
Goodwin PJ; Stambolic V
Breast; 2011 Oct; 20 Suppl 3():S31-5. PubMed ID: 22015290
[TBL] [Abstract][Full Text] [Related]
9. [New perspectives for metformin in cancer therapy].
Loubière C; Dirat B; Tanti JF; Bost F
Ann Endocrinol (Paris); 2013 May; 74(2):130-6. PubMed ID: 23587351
[TBL] [Abstract][Full Text] [Related]
10. Metformin, an old drug, brings a new era to cancer therapy.
He H; Ke R; Lin H; Ying Y; Liu D; Luo Z
Cancer J; 2015; 21(2):70-4. PubMed ID: 25815846
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
Guppy A; Jamal-Hanjani M; Pickering L
Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
[TBL] [Abstract][Full Text] [Related]
12. [Metformin, an antidiabetic molecule with anti-cancer properties].
Beck E; Scheen AJ
Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
[TBL] [Abstract][Full Text] [Related]
13. Metformin: taking away the candy for cancer?
Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
[TBL] [Abstract][Full Text] [Related]
14. Metformin: current clinical applications in nondiabetic patients with cancer.
Chen K; Li Y; Guo Z; Zeng Y; Zhang W; Wang H
Aging (Albany NY); 2020 Feb; 12(4):3993-4009. PubMed ID: 32074084
[TBL] [Abstract][Full Text] [Related]
15. Metformin: New Preparations and Nonglycemic Benefits.
Fujita Y; Inagaki N
Curr Diab Rep; 2017 Jan; 17(1):5. PubMed ID: 28116648
[TBL] [Abstract][Full Text] [Related]
16. Metformin and cancer therapy.
Bost F; Sahra IB; Le Marchand-Brustel Y; Tanti JF
Curr Opin Oncol; 2012 Jan; 24(1):103-8. PubMed ID: 22123231
[TBL] [Abstract][Full Text] [Related]
17. Metformin, cancer and glucose metabolism.
Salani B; Del Rio A; Marini C; Sambuceti G; Cordera R; Maggi D
Endocr Relat Cancer; 2014; 21(6):R461-71. PubMed ID: 25273809
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?
Shah RR
Drug Saf; 2017 Mar; 40(3):211-228. PubMed ID: 27981444
[TBL] [Abstract][Full Text] [Related]
19. The effect of metformin on biomarkers and survivals for breast cancer- a systematic review and meta-analysis of randomized clinical trials.
Zhang ZJ; Yuan J; Bi Y; Wang C; Liu Y
Pharmacol Res; 2019 Mar; 141():551-555. PubMed ID: 30664988
[TBL] [Abstract][Full Text] [Related]
20. Metformin in Oncology - How Far Is Its Repurposing as an Anticancer Drug?
Pácal L; Kaňková K
Klin Onkol; 2020; 33(2):107-113. PubMed ID: 32303131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]